No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Additionally, the company diversifies its activities into property development, real estate management, and leasing services. Founded in Changchun, China, in 1993, this enterprise was previously known as Changchun High & New Technology Industry (Group) Inc.
www.ccht.jl.cnNo one on the platform currently holds 000661.SZ.
No tracked institution reports a position in 000661.SZ as of their last filing.
No one on the platform has traded 000661.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 1.6% | 23.7% | 29.2% | — | — | — |
| Rev. Growth % | -10.3% | 7.1% | ||||
| Profit Margin % | 1.3% | 23.9% | 23.1% | |||
| Free Cash Flow Margin % | ||||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $11.9B | -15.8% | $2.48 | $2.21–$2.75 | — | 2 |
| 2027 | $13.0B | +9.7% | $3.23 | $2.64–$3.83 | — | 2 |
| 2028 | $14.7B | +13.1% | $3.95 | $3.82–$4.08 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-04-21 | $2.27 | $1.17 | -48.5% |
| 2025-04-20 | $2.10 | $-0.51 | -124.3% |
| 2024-10-25 | $2.10 | $2.69 | +28.1% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 000661.SZChangchun High-Tech Industries (Group) Inc. | $71.70 | -0.77% | $29.2B | — |
| 000538.SZYunnan Baiyao Group Co.,Ltd | $50.74 | -0.04% | $90.5B | — |
| 002007.SZHualan Biological Engineering Inc. | $12.86 | -1.61% | $23.5B | — |
| 300015.SZAier Eye Hospital Group Co., Ltd. | $7.99 | -0.87% | $74.3B | — |
| 300122.SZChongqing Zhifei Biological Products Co., Ltd. |
| $12.21 |
| -2.40% |
| $29.2B |
| — |
| 300142.SZWalvax Biotechnology Co., Ltd. | $13.01 | -2.84% | $20.8B | — |
| 300436.SZFujian Cosunter Pharmaceutical Co., Ltd. | $84.88 | -2.23% | $13.5B | — |
Source: Financial Modeling Prep · peers by sector/industry